Capital Fund Management S.A. Purchases 89,933 Shares of Cognex Corporation $CGNX

Capital Fund Management S.A. raised its position in shares of Cognex Corporation (NASDAQ:CGNX) by 115.5% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 167,787 shares of the scientific and technical instruments company’s stock after acquiring an additional 89,933 shares during the quarter. Capital Fund Management S.A. owned approximately 0.10% of Cognex worth $5,005,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of CGNX. Barclays PLC boosted its position in Cognex by 78.2% during the 4th quarter. Barclays PLC now owns 148,060 shares of the scientific and technical instruments company’s stock valued at $5,310,000 after acquiring an additional 64,953 shares in the last quarter. First Trust Advisors LP boosted its position in Cognex by 18.5% during the 4th quarter. First Trust Advisors LP now owns 89,544 shares of the scientific and technical instruments company’s stock valued at $3,211,000 after acquiring an additional 13,951 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Cognex by 6.6% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,902,930 shares of the scientific and technical instruments company’s stock valued at $68,239,000 after acquiring an additional 117,089 shares in the last quarter. BI Asset Management Fondsmaeglerselskab A S boosted its position in Cognex by 39.1% during the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 2,817 shares of the scientific and technical instruments company’s stock valued at $101,000 after acquiring an additional 792 shares in the last quarter. Finally, MetLife Investment Management LLC boosted its position in Cognex by 9.0% during the 4th quarter. MetLife Investment Management LLC now owns 97,099 shares of the scientific and technical instruments company’s stock valued at $3,482,000 after acquiring an additional 8,030 shares in the last quarter. 88.12% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several analysts have weighed in on CGNX shares. Needham & Company LLC lifted their price objective on Cognex from $36.00 to $45.00 and gave the company a “buy” rating in a research report on Thursday, July 31st. Citigroup reissued a “neutral” rating and issued a $37.00 price target (up from $30.00) on shares of Cognex in a research report on Monday, July 14th. Robert W. Baird boosted their price target on Cognex from $30.00 to $32.00 and gave the stock a “neutral” rating in a research report on Monday, June 16th. UBS Group boosted their price target on Cognex from $53.00 to $58.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Finally, The Goldman Sachs Group boosted their price target on Cognex from $29.00 to $32.00 and gave the stock a “sell” rating in a research report on Thursday, June 12th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Cognex currently has an average rating of “Moderate Buy” and a consensus price target of $42.31.

Cognex Stock Up 4.7%

Shares of CGNX opened at $44.76 on Friday. The business’s 50 day moving average price is $35.85 and its 200-day moving average price is $32.14. Cognex Corporation has a 52 week low of $22.67 and a 52 week high of $44.87. The stock has a market cap of $7.52 billion, a P/E ratio of 63.04 and a beta of 1.47.

Cognex (NASDAQ:CGNX) last released its quarterly earnings data on Wednesday, July 30th. The scientific and technical instruments company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The business had revenue of $249.09 million for the quarter, compared to analysts’ expectations of $246.70 million. Cognex had a return on equity of 6.65% and a net margin of 13.13%.The firm’s quarterly revenue was up 4.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.23 EPS. Cognex has set its Q3 2025 guidance at 0.240-0.290 EPS. On average, equities analysts anticipate that Cognex Corporation will post 0.61 EPS for the current year.

Cognex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, August 28th. Investors of record on Thursday, August 14th will be given a $0.08 dividend. The ex-dividend date of this dividend is Thursday, August 14th. This represents a $0.32 annualized dividend and a yield of 0.7%. Cognex’s dividend payout ratio is 45.07%.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.